[Shrinkage of uterine leiomyomas after intranasal administration of a LHRH agonist].
Uemura
T
T
Department of Obstetrics, University School of Medicine.
Kimura
A
A
Shirasu
K
K
Minaguchi
H
H
D000281:Administration, Intranasal; D000328:Adult; D002064:Buserelin / Q000008:administration & dosage / Q000627:therapeutic use*; D004341:Drug Evaluation; D004958:Estradiol / Q000097:blood; D005260:Female; D006801:Humans; D007889:Leiomyoma / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D012074:Remission Induction; D014463:Ultrasonography; D014594:Uterine Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D014599:Uterus / Q000473:pathology
D004958:Estradiol; D002064:Buserelin